Citations

Clear

1792 citation(s) found for "Stephanie".

Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder
Gutiérrez-Fragoso, Karina , Amare, Azmeraw T. , Adli, Mazda , Akiyama, Kazufumi , Akula, Nirmala , Ardau, Raffaella , Arias, Bárbara , Aubry, Jean‐Michel , Benabarre, Antonio , Bengesser, Susanne , Abesh, Bhattacharjee, Birner, Armin , Cearns, Micah , Cervantes, Pablo , Chillotti, Caterina , Cichon, Sven , Clark, Scott R. , Dalkner, Nina , Zompo, Maria Del , Forstner, Andreas J. , Frank, Josef , Frisén, Louise , Frye, Mark A. , Gard, Sébastien, Grof, Paul , Hsu, Yi‐Hsiang , Kahn, Jean‐Pierre, Kassem, Layla, Laje, Gonzalo, Landén, Mikael , Lavebratt, Catharina , Leckband, Susan G. , Maj, Mario , Mitjans, Marina , Mondimore, Francis M. , Nöthen, Markus M. , O’Donovan, Claire , Pisanu, Claudia , Potash, James B. , Richard-Lepouriel, Hélène , Roberts, Gloria , Schalling, Martin , Schweizer, Barbara , Severino, Giovanni , Shekhtman, Tatyana , Shilling, Paul D. , Shimoda, Kazutaka , Simhandl, Christian , Slaney, Claire , Stamm, Thomas , Streit, Fabian , Veeh, Julia, Witt, Stephanie H. , Zandi, Peter P. , Bauer, Michael , Herrera-Rivero, Marisol , Amare, Azmeraw , Arias, Bárbara , Biernacka, Joanna , Cearns, Micah , Chen, Hsi-Chung , Clark, Scott , Cruceanu, Cristiana , Czerski, Piotr , Del Zompo, Maria , DePaulo, J Raymond , Forstner, Andreas J , Frank, Josef , Frye, Mark , Fullerton, Janice M , Garnham, Julie , Grigoroiu-Serbanescu, Maria , Hashimoto, Ryota , Hauser, Joanna , Heilbronner, Urs , Hou, Liping , Hsu, YiHsiang, Jamain, Stéphane , Kelsoe, John R , Kuo, Po-Hsiu , Kusumi, Ichiro , Landén, Mikael , Lavebratt, Catharina , Leboyer, Marion , Marie-Claire, Cynthia , Nievergelt, Caroline M , Novak, Tomas , Nöthen, Markus M , Ozaki, Norio , Papiol, Sergi , Pisanu, Claudia , Reif, Andreas , Reininghaus, Eva , Rouleau, Guy Armand , Rybakowski, Janusz K , Schalling, Martin , Schofield, Peter R , Schubert, Klaus Oliver , Schulte, Eva , Severino, Giovanni , Shimoda, Kazutaka , Squassina, Alessio , Streit, Fabian , Turecki, Gustavo , Vieta, E , Viswanath, Biju , Witt, Stephanie H , Alda, Martin , Bauer, M , McMahon, Francis , Mitchell, Philip B , Rietschel, Marcella , Schulze, Thomas , Cichon, Sven , Mitjans, Marina , Thalamuthu, Anbupalam , Backlund, Lena , Bellivier, Frank , Biernacka, Joanna M. , Chen, Hsi‐Chung , Colom, Francesc , Cruceanu, Cristiana , Czerski, Piotr M. , Dalkner, Nina , Degenhardt, Franziska , Étain, Bruno , Falkai, Peter , Ferensztajn‐Rochowiak, Ewa , Fullerton, Janice M. , Gallo, Carla , Goes, Fernando , Grigoroiu‐Serbânescu, Maria , Hashimoto, Ryota , Hasler, Roland , Heilbronner, Urs , Herms, Stefan , Hoffmann, Per , Jamain, Stéphane , Jiménez, Esther , Kato, Tadafumi , Kittel‐Schneider, Sarah , Kuo, Po‐Hsiu , Kurtz, Joachim , König, Barbara , Leboyer, Marion , Manchia, Mirko , Martinsson, Lina , McCarthy, Michael J. , McElroy, Susan L. , Millischer, Vincent , Monteleone, Palmiero , Novák, Tomáš , Ozaki, Norio , Papiol, Sergi , Pfennig, Andrea , Reif, Andreas , Schofield, Peter R. , Schubert, Klaus Oliver , Schulte, Eva C. , Squassina, Alessio , Stopková, Pavla , Tekola‐Ayele, Fasil , Tortorella, Alfonso , Turecki, Gustavo , Vieta, Eduard , Viswanath, Biju , Alda, Martin , McMahon, Francis J. , Baune, Bernhard

Mayo Clinic

No container title available | June 26, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3068352/v1 | PMID 37461719 Get It

Abstract The link between bipolar disorder (BP) and immune dysfunction remains controversial. While epidemiological studies have long suggested an association, recent research has found only limited evidence of such a relationship. To clarify this, we investigated the contributions of immune-relevant genetic factors to the response to lithium (Li) treatment and the clinical presentation of BP. First, we assessed the association of a large collection of immune-related genes (4,925) with Li response, defined by the Retrospective Assessment of the Lithium Response Phenotype Scale (Alda scale), and clinical characteristics in patients with BP from the International Consortium on Lithium Genetics (ConLi+Gen, N = 2,374). Second, we calculated here previously published polygenic scores (PGSs) for immune-related traits and evaluated their associations with Li response and clinical features. We found several genes associated with Li response at p < 1x10− 4 values, including HAS3, CNTNAP5 and NFIB. Network and functional enrichment analyses uncovered an overrepresentation of pathways involved in cell adhesion and intercellular communication, which appear to converge on the well-known Li-induced inhibition of GSK-3β. We also found various genes associated with BP’s age-at-onset, number of mood episodes, and presence of psychosis, substance abuse and/or suicidal ideation at the exploratory threshold. These included RTN4, XKR4, NRXN1, NRG1/3 and GRK5. Additionally, PGS analyses suggested serum FAS, ECP, TRANCE and cytokine ligands, amongst others, might represent potential circulating biomarkers of Li response and clinical presentation. Taken together, our results support the notion of a relatively weak association between immunity and clinically relevant features of BP at the genetic level.
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model
Blau, Sibel , Peguero, Julio A. , Moore, Halle C. F. , Anderson, Ian Churchill, Cherian, Mathew , Elkhanany, Ahmed , O’Sullivan, Ciara C. , Moreno‐Aspitia, Alvaro , Plourde, Paul V., Gleich, Lyon L., Riesen, Kendra, Ezzati, Ross, Degele, Meghan, Shulman, Megan, Stempf, Stephanie Dobson, Sachse, Laura, Iyer, Amrita A. , Cooney, Matthew M. , Peguero, Julio Antonio , Cherian, Mathew Amprayil , Elkhanany, Ahmed , O'Sullivan, Ciara Catherine , Moreno-Aspitia, Alvaro , Iyer, Amrita A , Damodaran, Senthil , Moore, Halle C F , Barve, Minal

Mayo Clinic

JCO Clinical Cancer Informatics | June 23, 2023 | Volume: No volume available | Issue: 7 | Pages: No page available

10.1200/cci.22.00164 | PMID 37352479 Get It

PURPOSEThere are numerous barriers to enrollment in oncology biomarker-driven studies.METHODSThe ELAINE 2 study (ClinicalTrials.gov identifier: NCT04432454 ) is an open-label phase 2 study of lasofoxifene combined with abemaciclib in patients with advanced or metastatic estrogen receptor–positive/human epidermal growth factor receptor 2–negative breast cancer with an ESR1 mutation. ELAINE 2 opened clinical sites by using a Traditional approach, which activated a site before patient identification, and the Tempus TIME Trial network, which opened a site only after identifying an eligible patient. This manuscript presents the operational metrics comparing the Traditional and TIME Trial site data.RESULTSThe study enrolled patients over 34 weeks and 16 sites (six Traditional and 10 TIME Trial) participated. Duration for full clinical trial agreement execution for Traditional sites and TIME Trial sites averaged 200.5 (range, 142-257) and 7.6 days (range, 2-14), respectively. Institutional review board approval time for Traditional sites and TIME Trial sites was 27.5 (range, 12-71) and 3.0 days (range, 1-12), respectively. Duration from study activation to first consent was 33.3 (range, 18-58) and 8.8 days (range, 1-35) for Traditional and TIME Trial sites, respectively. The first patient on study was at a TIME Trial site 115 days before a Traditional site and the first seven patients enrolled were at TIME Trial sites. Traditional sites consented 23 and enrolled 16 patients, while TIME Trial sites consented 16 and enrolled 13. The trial enrolled 29 patients in 8.5 months with the anticipated enrollment duration being 12-18 months.CONCLUSIONThe TIME Trial network opened earlier and enrolled the first study patients. These results demonstrate that the Just-in-TIME model, along with a Traditional model, can improve enrollment in biomarker-driven studies.
Emergence of Inducible Macrolide Resistance in Mycobacterium chelonae Due to Broad-Host-Range Plasmid and Chromosomal Variants of the Novel 23S rRNA Methylase Gene, erm (55)
Brown‐Elliott, Barbara A. , Wallace, Richard J. , Wengenack, Nancy L. , Workman, Sean D. , Cameron, Andrew D. S. , Bush, Georgie, Hughes, M. Dolores, Melton, Stephanie, Gonzalez-Ramirez, Bibiana, Rodrı́guez, Eliana , Somayaji, Kavya, Klapperich, Courtney, Viers, Mary, Bolaji, Ayooluwa , Rempel, Emma , Alexander, David C. , Rodriguez, Eliana, Rempel, Emma

Mayo Clinic

Journal of Clinical Microbiology | June 23, 2023 | Volume: 61 | Issue: 7 | Pages: No page available

10.1128/jcm.00428-23 | PMID 37347171 Get It

Macrolides are a mainstay of therapy for infections due to nontuberculous mycobacteria (NTM). Among rapidly growing mycobacteria (RGM), inducible macrolide resistance is associated with four chromosomal 23S rRNA methylase ( erm ) genes.
Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Redenbaugh, Vyanka , Chen, John J. , Morris, Pearse , Sechi, Elia , López‐Chiriboga, A. Sebastian , Tillema, Jan‐Mendelt , Rocca, Maria A. , Filippi, Massimo , Pittock, Sean J. , Pittock, S J , Sechi, Elia , Syc-Mazurek, Stephanie B , Rocca, Maria A , Filippi, Massimo , Chen, John J , Cacciaguerra, Laura , Syc‐Mazurek, Stephanie B. , Flanagan, Eoin P.

Mayo Clinic

Neurology | June 19, 2023 | Volume: 101 | Issue: 13 | Pages: No page available

10.1212/wnl.0000000000207478 | PMID 37336767 Get It

Transcriptome profiling in AD cases to identify distinct associations with AD‐related neuropathology and protein levels in the brain
Allen, Mariet , Quicksall, Zachary , Wang, Xue , Reddy, Joseph S. , Bergman, Jeremiah, Oatman, Stephanie R., Nguyen, Thuy , Malphrus, Kimberly G., Lincoln, Sarah, Martens, Yuka A. , DeTure, Michael , Kanekiyo, Takahisa , Ertekin‐Taner, Nilüfer , Yamazaki, Yu , Zhao, Na , Murray, Melissa E. , Liu, Chia‐Chen , Dickson, Dennis W. , Bu, Guojun

Mayo Clinic

Alzheimer's & Dementia | June 16, 2023 | Volume: 19 | Issue: S1 | Pages: No page available

10.1002/alz.067201 Get It

AbstractBackgroundGene expression changes have been identified in post‐mortem brain tissue of AD cases when compared with controls, implicating various genes and pathways. Such findings provide important insights into molecular dysregulation associated with this disease and nominate therapeutic targets. Here we investigate brain gene and co‐expression network changes in a cohort of AD cases to identify associations with degree of AD neuropathology including Braak stage (Tau), Thal phase (Amyloid beta) and brain tissue levels of five AD‐related proteins (apoE, Aβ40, Aβ42, tau, and p‐tau).MethodGene expression measures were collected from temporal cortex (TCX) tissue of 477 AD cases, available through the Mayo Clinic Brain Bank, using RNA sequencing (Illumina TruSeq mRNA) performed on the HiSeq4000. Following quality control 456 cases remained for analysis. Braak and Thal were provided by an experienced neuropathologist and TCX levels of five AD‐related proteins from three fractions (buffer‐soluble, detergent‐soluble, and insoluble) were measured by ELISA (Liu et al. 2020). Weighted gene coexpression network analysis (WGCNA) R package was used to build co‐expression networks. Genes and networks were tested for association with neuropathology and AD‐related protein levels, adjusting for relevant covariates.ResultA total of 57,353 genes were profiled, of which 19,044 were reliably expressed above background levels and formed 20 co‐expression modules. 36 genes were associated with Braak stage, 10 with Thal phase and up to 9,000 with the AD‐related protein fractions. Brain levels of pTau had the greatest number of associations, with an overrepresentation of genes involved in synaptic signalling and immune response gene ontology biological processes. 16 of the coexpression modules associated with at least one trait after Bonferroni correction for number of tests.ConclusionWe have identified a number of genes and networks associated with different aspects of AD neuropathology and associated proteins, further lending support to the involvement of synaptic and immune biology in AD. However it is not clear whether observed changes cause disease or are a consequence of the neurodegenerative process. Comparison of these findings across different proteins and fractions is expected to reveal common and distinct vulnerabilities associated with amyloid and tau, and different stages of protein aggregation.
Abstract 12681: GWAS Meta-Analysis in SCAD, a Women Predominant Ischemic Heart Disease, Reveals Common Variants and Genes Related to Artery Integrity and Tissue-Mediated Coagulation
Adlam, David , Ma, Lijiang , Blencowe, Montgomory, Turley, Tamiel N. , Yang, Min‐Lee , Junday, Keerat , CARDIoGRAMPlusC4D, investigators, DISCO register, Saw, Jacqueline , Xia, Yang, Samani, Nilesh J. , Berrandou, Takiy-Eddine , Georges, Adrien , Nelson, Christopher P. , Giannoulatou, Eleni , Iismaa, Siiri E. , Tarr, Ingrid S. , Muller, David W. , Hesselson, Stephanie , Fatkin, Diane , CARDIoGRAMPlusC4D, Combaret, Nicolas , investigators, DISCO register, Webb, Tom R. , Tweet, Marysia S. , Hayes, Sharonne N. , Yang, Xia , Ganesh, Santhi K. , Olson, Timothy M. , Kovacic, Jason C. , Graham, Robert M. , Bouatia‐Naji, Nabila

Mayo Clinic

Circulation | June 15, 2023 | Volume: 146 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.146.suppl_1.12681 Get It

Introduction: Spontaneous coronary artery dissection (SCAD) is an understudied cause of acute myocardial infarction due to hematoma formation in coronary arteries primarily affecting women. It is not known to what extent SCAD is genetically distinct from other cardiovascular diseases, including atherosclerotic coronary artery disease (CAD). Methods and Results: Through a meta-analysis of 8 GWAS (1917 cases, 9292 controls of European ancestry), we identified 17 risk loci, including 12 new. Functional annotations pointed at enrichment in enhancer marks of arteries, specifically smooth muscle cells, and strong candidate genes, such as tissue factor gene ( F3 ) on Chr1 near rs1146473 (OR=1.32, P=5.8 х10 -9 ). F3 is novel for SCAD or any cardiovascular disease. The risk allele correlated with F3 lower expression in arteries, supporting a mechanism consistent with hematoma formation. Bayesian gene regulatory networks constructed from expression and genetics data indicated the extracellular matrix organization in arteries as the biological function where most prioritized genes clustered (e.g. COL4A1/A2, HTRA1, and TIMP3 ). Overall, we report substantial polygenicity for SCAD (LDSC: h 2 SNP = 0.71 ± 0.11) and shared genetics with several neurovascular diseases (e.g intracranial aneurysm). Intriguingly, for 6 loci, colocalization analyses showed that SCAD and CAD are likely to share the same causal variants but involve opposite risk alleles (e.g COL4A1/A2 ). In addition, a negative genetic correlation was found between SCAD and CAD (rg=-0.12; P=3.7х10 -3 ), including after conditioning on BP (mt-COJO: rg CAD/SBP =-0.19, P=4.6х10 -6 ). Mendelian randomization analyses indicated higher BP to associate with increased risk for SCAD (beta IVW-SBP =0.05, P=7.6х10 -6 , beta IVW-DBP =0.10, P=1.9х10 -6 ) and CAD (beta IVW-SBP =0.04, P=8.6х10 -49 ; DBP: beta IVW-DBP =0.06, P=1.6х10 -44 ) but not BMI, lipids, or type 2 diabetes, which we confirmed as genetic risk factors for CAD Conclusions: Our results set the stage for future investigation of novel biological pathways relevant to both SCAD and CAD and potential therapeutic and preventive strategies specifically targeting this ischemic disease predominantly affecting women.
Gender disparity in the effects of COVID‐19 on academic productivity and career satisfaction in anesthesiology in the US: Results of a national survey of anesthesiologists
Jankowska, Anna , Pai, Sher‐Lu , Lee, Jennifer K. , Nyshadham, Soumya, Diachun, Carol Ann B., Byerly, Stephanie I., Hertzberg, Linda B., Berenstain, Laura K. , Pai, Sher-Lu , Austin, Thomas M.

Mayo Clinic

Gender, Work & Organization | June 12, 2023 | Volume: 30 | Issue: 5 | Pages: 1741-1758

10.1111/gwao.13016 Get It

AbstractThe coronavirus disease 2019 (COVID‐19) pandemic created unprecedented challenges for anesthesiologists both at work and home. This study examined whether the pandemic affected academic productivity and career satisfaction among anesthesiologists practicing in the United States during the early stages of the pandemic and whether these effects differed by gender. A survey was emailed to 25,473 members of the American Society of Anesthesiologists to learn about their experiences during the beginning of the pandemic. The survey directed respondents to rate their change in academic productivity, clinical care hours, scholarly and leadership opportunities, income, childcare duties, and household responsibilities during the first 5 months of the pandemic (March 1–July 31, 2020). The primary variable was gender, academic productivity was the primary outcome, and data were analyzed by multivariable proportional odds logistic regression models and correlations. Female anesthesiologists reported lower academic productivity and career satisfaction relative to male anesthesiologists during the study period. Career satisfaction positively correlated with academic productivity. Compared to male anesthesiologists, female anesthesiologists also had more household responsibilities before and during the pandemic. Being a female parent reduced academic productivity relative to that reported by nonparents of either gender. In conclusion, the early months of the COVID‐19 pandemic had a greater adverse professional impact on female anesthesiologists than on their male counterparts. Efforts to support and retain female anesthesiologists, particularly those early in their careers and those with children, are essential for the specialty to maintain its workforce and promote gender equity in promotion and leadership.
THE PROGNOSTIC IMPACT OF CLINICAL FACTORS AND IMMUNOARCHITECTURAL PATTERNS FOR NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA: AN INTERNATIONAL STUDY BY GLOW
Binkley, Michael S., Borchmann, Peter , Fuchs, Michael , Hartmann, Sylvia , Eich, Hans Theodor, Skinnider, Brian, Steiner, Raphaël , Milgrom, Sarah A. , Alomari, Mohammed H., Zhang, Xieyi , Advani, Ranjana H. , Metzger, Monika L. , Wirth, A., Smith, Sonali M. , Hendrickson, P., Hopkins, David , Ng, Andrea K. , Koenig, Julie L. , Sakthivel, GD, Roberts, Kenneth B. , Gao, Sarah , Kendi, J. Al, Rahbi, Nasser Al, Balogh, Alex, Torka, Pallawi , Silva, Ravi De , Shah, Nimish , Osborne, Wendy , Henry, M M , Chang, Ilsung , Miall, Fiona , Brady, J.L. , Mikhaeel, G., Brennan, Barbara J. , Penn, Andrew M. , Сенченко, М. А. , Reeves, Mark E. , Terezakis, Stephanie , Fergusson, Pamela, Kelly, Kara M. , Advani, Ranjana H , Hopkins, David , Senchenko, Maria Anatolevna , Binkley, Michael S. , Flerlage, Jamie E. , Savage, Kerry J. , Hodgson, David C. , Akhtar, Saad , Rauf, M. Shahzad , Maghfoor, Irfan , Pinnix, Chelsea C. , Vega, Francisco , Alomari, M., Zhang, X., Collins, Graham P. , Dickinson, Michael , Tsang, Richard , Prica, Anca A. , Major, Ajay , Kelsey, Chris R. , McKay, Pamela , Constine, Louis S , Casulo, Carla , Baron, J., Plastaras, John Peter , Kendi, J. Al, Levis, Mario , Ricardi, Umberto , Sridhar, A., Specht, Lena , Pickard, Keir , Blazin, Lindsay , Henry, M., Chang, I., Smith, Christine M , Halperin, Daniel M. , Brennan, B., Penn, A., Volchkov, Egor Vasilevich , Reeves, M., Hoppe, Bradford S. , Talaulikar, Dipti , Pepa, Roberta Della , Picardi, Marco , Kirova, Youlia , Fergusson, P., Northend, Michael , Shankar, Ananth , Maurer, Matthew J. , Natkunam, Yasodha , Eichenauer, Dennis A. , Hoppe, Richard T.

Mayo Clinic

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 100-101

10.1002/hon.3163_62 Get It

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
Cho, S. , Poon, Michelle, Champion, Rebecca, Guidez, Stéphanie , Jagadeesh, Deepa , Oliveira, Carolina Leite De, Chaudhry, A., Ambati, Srikanth, Kim, T. M., Novelli, Silvana , Luminari, Stefano , Taszner, Michał , Gouill, Steven Le , Villasboas, José C. , Bachy, Emmanuel , Alonso, Aránzazu , Merli, Michele , Tucker, David , Cai, James J. , Zhu, Min , Mohamed, Hesham , Kim, Tae Min

Mayo Clinic

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 121-122

10.1002/hon.3163_82 Get It

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease
Schultz, Stephanie A. , Shirzadi, Zahra , Liu, Lei , Fitzpatrick, Colleen , Barthélemy, Nicolas R. , Esposito, Bianca, Chen, Charles D., Goate, Alison , Berman, Sarah , Chui, Helena C., Fagan, Anne M. , Farlow, Martin R. , Fox, Nick C. , Gordon, Brian A. , Day, Gregory S. , Graff‐Radford, Neill R. , Hassenstab, Jason , Hanseeuw, Bernard , Hofmann, Anna, Levey, Allan I. , Xiong, Chengjie , Mori, Hiroshi , Morris, John C. , Perrin, Richard J. , Salloway, Stephen , Johnson, Keith A. , Chhatwal, Jasmeer P. , Investigators, the Dominantly Inherited Alzheimer Network, Vöglein, Jonathan , Liu, Lei , Gordon, Brian A , Day, Gregory S , Vöglein, Jonathan , Xiong, Chengjie , Chen, Charles D , Fox, Nick C , Hassenstab, Jason , Morris, John C , Goate, Alison M , Berman, Sarah , Levey, Allan I , Schultz, Aaron P. , McDade, Eric , Renton, Alan , Joseph‐Mathurin, Nelly , Cruchaga, Carlos , Allegri, Ricardo , Benzinger, Tammie L.S. , Chui, Helena C. , Jack, Clifford R. , Jucker, Mathias , Karch, Celeste M. , Koeppe, Robert A. , Lee, Jae‐Hong , Martins, Ralph N. , Noble, James M. , Rosa-Neto, Pedro , Sánchez‐Valle, Raquel , Schofield, Peter R. , Xiong, Chengjie , Bateman, Randall J. , Sperling, Reisa Anne , Investigators, the Dominantly Inherited Alzheimer Network

Mayo Clinic

Aging Cell | June 9, 2023 | Volume: 22 | Issue: 8 | Pages: No page available

10.1111/acel.13871 | PMID 37291760 Get It

AbstractAlthough pathogenic variants in PSEN1 leading to autosomal‐dominant Alzheimer disease (ADAD) are highly penetrant, substantial interindividual variability in the rates of cognitive decline and biomarker change are observed in ADAD. We hypothesized that this interindividual variability may be associated with the location of the pathogenic variant within PSEN1. PSEN1 pathogenic variant carriers participating in the Dominantly Inherited Alzheimer Network (DIAN) observational study were grouped based on whether the underlying variant affects a transmembrane (TM) or cytoplasmic (CY) protein domain within PSEN1. CY and TM carriers and variant non‐carriers (NC) who completed clinical evaluation, multimodal neuroimaging, and lumbar puncture for collection of cerebrospinal fluid (CSF) as part of their participation in DIAN were included in this study. Linear mixed effects models were used to determine differences in clinical, cognitive, and biomarker measures between the NC, TM, and CY groups. While both the CY and TM groups were found to have similarly elevated Aβ compared to NC, TM carriers had greater cognitive impairment, smaller hippocampal volume, and elevated phosphorylated tau levels across the spectrum of pre‐symptomatic and symptomatic phases of disease as compared to CY, using both cross‐sectional and longitudinal data. As distinct portions of PSEN1 are differentially involved in APP processing by γ‐secretase and the generation of toxic β‐amyloid species, these results have important implications for understanding the pathobiology of ADAD and accounting for a substantial portion of the interindividual heterogeneity in ongoing ADAD clinical trials.